Dehar, Navdeep

Medical Oncology

Clinical Assistant Professor

Biography

Dr. Navdeep Dehar is a Medical Oncologist and an Assistant Professor in the Department of Oncology at the University of Calgary’s Cumming School of Medicine, as well as a staff medical oncologist at the Arthur Child Comprehensive Cancer Center. With a robust research background spanning over 10 years, Dr. Dehar has worked in various research settings, guiding numerous research projects from conception to completion. Currently, she serves as both a primary and sub-investigator on several clinical trials focusing on gastrointestinal cancers.

Dr. Dehar has also contributed significantly to the ethical oversight of research as a former ethics reviewer at the Conjoint Health Research Ethics Board at the University of Calgary and as Co-Chair of the Calgary Chapter of the Clinical Research Association of Canada (CRAC). Her scholarly contributions include numerous publications in peer-reviewed journals and presentations at both national and international conferences.

A passionate clinician and researcher, Dr. Dehar aims to make a global impact through her work. Her achievements have been recognized with several honors, including the Young Scientist Award and the Dr. Chirag Shah International Medical Graduate Award.

Recently, Dr. Dehar completed a year-long Clinical Research Fellowship at the Canadian Cancer Trials Group, further enhancing her expertise and preparing her to explore new avenues in clinical and academic research.

Area of Focus

Summary of Research

Clinical, Research and Academic Interests

Gastrointestinal Cancers – Precision Medicine, Patient related outcomes (PRO) & Real World Outcomes (RWO)
Quality improvement in clinical trials and patient care
Patient and physician education initiatives

Publications:

Pichler T, Mumm F, Dehar N, Dickman E, Díez de Los Ríos de la Serna C, Dinkel A, Heinrich K, Hennink M, Parviainen AD, Raske V, Wicki N, Moore AC. Understanding communication between patients and healthcare professionals regarding comprehensive biomarker testing in precision oncology: A scoping review. Cancer Med. 2024 13(3):e6913. doi: 10.1002/cam4.6913 Epub 2024 Jan 31. PMID: 38298115; PMCID: PMC10905543.
Dehar, N.; Jabs, D.; Hopman, W.; Mates, M. A Retrospective Analysis of Diagnostic Breast Imaging Outcomes in Young Women at a Tertiary Care Center. Oncol.2024, 31, 3939-3948. https://doi.org/10.3390/curroncol31070291
Dehar N, Meem M, Aggarwal I, et al. Brief Report: Real-world eligibility for clinical trials in patients with extensive-stage SCLC at a tertiary care center.JTO Clin Res Rep. 2024;5:100696.
Dehar N, Tong J, Siddiqui Z, Leveridge M, Tomiak A. Priapism in a Patient with Rectal Adenocarcinoma. Diseases2023;11(1):34. https://doi.org/10.3390/diseases11010034
Dehar, N.; Abedin, T.; Tang, P.; Bebb, G.; Cheung, W.Y. A Comparison of Patients’ and Physicians’ Knowledge and Expectations Regarding Precision Oncology Tests. Oncol.2022; (29): 9916-9927. https://doi.org/10.3390/curroncol29120780
Hazari H, Belenkie I, Kryski A, White J, Oudit G, Thompson R, Fung T, Dehar N, Khan A. Comparison of Echocardiography and Cardiac Magnetic Resonance Imaging in The Determination of Left Ventricular Mass Index in Fabry Molecular Genetics and Metabolism. 2016; 117: S14–S124.
Pollak PT, Dehar N, Herman RJ, Zarnke KB, Feldman RD. Generalized Additive Mixed Model (GAMM) to Characterize Ambulatory Systolic Blood Pressure (SBP) differences between alternate Nifedipine Osmotic Delivery Formulations. American Society of Pharmacology and Therapeutics (ASPT). 2016; Vol 99(Suppl 1): S50.
Pollak PT, Dehar N, Herman RJ, Zarnke KB. Ambulatory Monitoring Demonstrates Statistically Different 24- Hour and Nocturnal BP in Patients Switching between Nifedipine Osmotic Delivery Formulations. ClinPharmacolTherap 2015; 97(Suppl 1): S50-51.

Area Of Focus

Summary Of Research